235 related articles for article (PubMed ID: 26897358)
1. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.
Yang JL; Liu DX; Zhen SJ; Zhou YG; Zhang DJ; Yang LY; Chen HB; Feng Q
BMC Cancer; 2016 Feb; 16():131. PubMed ID: 26897358
[TBL] [Abstract][Full Text] [Related]
2. The immunoreactivity of the anti-p21Ras single-chain fragment variant KGH-R1 and its predicted binding sites to p21Ras.
Wang P; Pan X; Feng Q; Zou H; Cui J; He Y; Luo Y; Yang J
Immunotherapy; 2020 Aug; 12(12):879-890. PubMed ID: 32664770
[No Abstract] [Full Text] [Related]
3. The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300.
Pan XY; Liu XJ; Li J; Zhen SJ; Liu DX; Feng Q; Zhao WX; Luo Y; Zhang YL; Li HW; Yang JL
Gene Ther; 2017 Jan; 24(1):40-48. PubMed ID: 27834948
[TBL] [Abstract][Full Text] [Related]
4. Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains.
Cochet O; Kenigsberg M; Delumeau I; Duchesne M; Schweighoffer F; Tocqué B; Teillaud JL
Mol Immunol; 1998 Dec; 35(17):1097-110. PubMed ID: 10395199
[TBL] [Abstract][Full Text] [Related]
5. BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor.
Yu T; Shi Y; Pan X; Feng Q; Wang P; Song S; Yang L; Yang J
PLoS One; 2022; 17(6):e0269084. PubMed ID: 35648774
[TBL] [Abstract][Full Text] [Related]
6. RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480.
Huang CC; Liu FR; Feng Q; Pan XY; Song SL; Yang JL
BMC Cancer; 2021 Mar; 21(1):321. PubMed ID: 33765976
[TBL] [Abstract][Full Text] [Related]
7. RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP.
Lin P; Qian J; Huang CC; Xu WM; Wang YY; Gao ZR; Zheng SQ; Wang P; Jia DQ; Feng Q; Yang JL
BMC Cancer; 2024 Jan; 24(1):71. PubMed ID: 38216883
[TBL] [Abstract][Full Text] [Related]
8. The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo.
Yang JL; Pan XY; Zhao WX; Hu QC; Ding F; Feng Q; Li GY; Luo Y
Int J Oncol; 2016 Mar; 48(3):1218-28. PubMed ID: 26780944
[TBL] [Abstract][Full Text] [Related]
9. Establishment of four mouse hybridoma cell lines producing monoclonal antibodies reactive with ras oncogene product p21.
Kuzumaki N; Oda A; Yamagiwa S; Taniguchi N; Kobayashi H; Oikawa T
J Natl Cancer Inst; 1986 Dec; 77(6):1273-9. PubMed ID: 3540418
[TBL] [Abstract][Full Text] [Related]
10. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
11. [Immunoreactivity of monoclonal anti-p21Ras antibody KGH-R1 in colorectal benign and malignant lesions].
Chen HB; Liu DX; Wang L; Chen Y; Song SL; Yang LL; Hao Y; Yang JL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1206-9. PubMed ID: 21138685
[TBL] [Abstract][Full Text] [Related]
12. CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer.
Lin XR; Zhou XL; Feng Q; Pan XY; Song SL; Fang H; Lei J; Yang JL
J Cancer Res Clin Oncol; 2019 May; 145(5):1123-1132. PubMed ID: 30796510
[TBL] [Abstract][Full Text] [Related]
13. Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells.
Liu FR; Bai S; Feng Q; Pan XY; Song SL; Fang H; Cui J; Yang JL
BMC Cancer; 2018 Nov; 18(1):1087. PubMed ID: 30419845
[TBL] [Abstract][Full Text] [Related]
14. A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites.
Werge TM; Bradbury A; Di Luzio A; Cattaneo A
Oncogene; 1992 May; 7(5):1033-5. PubMed ID: 1570149
[TBL] [Abstract][Full Text] [Related]
15. Construction, expression and characterisation of a single chain variable fragment in the Escherichia coli periplasmic that recognise MCF-7 breast cancer cell line.
Mahgoub EO; Bolad AK
J Cancer Res Ther; 2014; 10(2):265-73. PubMed ID: 25022376
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.
Bai S; Feng Q; Pan XY; Zou H; Chen HB; Wang P; Zhou XL; Hong YL; Song SL; Yang JL
Int J Mol Med; 2017 Apr; 39(4):861-868. PubMed ID: 28259994
[TBL] [Abstract][Full Text] [Related]
17. Isolated limb perfusion based anti-p21ras gene therapy in a rat rhabdomyosarcoma.
Van Etten B; Van Tiel ST; Ambagtsheer G; Eggermont AM; Ten Hagen TL
Anticancer Res; 2004; 24(4):2295-301. PubMed ID: 15330175
[TBL] [Abstract][Full Text] [Related]
18. The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine.
Jain S; Aresu L; Comazzi S; Shi J; Worrall E; Clayton J; Humphries W; Hemmington S; Davis P; Murray E; Limeneh AA; Ball K; Ruckova E; Muller P; Vojtesek B; Fahraeus R; Argyle D; Hupp TR
PLoS One; 2016; 11(2):e0148366. PubMed ID: 26894679
[TBL] [Abstract][Full Text] [Related]
19. A single-chain antibody fragment against human thyroglobulin: construction and evaluation of immunoreactivity.
Rajawat R; Narkar A; Damle A; Kumar GB; Mishra KP
Hybridoma (Larchmt); 2011 Jun; 30(3):253-9. PubMed ID: 21707360
[TBL] [Abstract][Full Text] [Related]
20. Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression.
Cochet O; Kenigsberg M; Delumeau I; Virone-Oddos A; Multon MC; Fridman WH; Schweighoffer F; Teillaud JL; Tocqué B
Cancer Res; 1998 Mar; 58(6):1170-6. PubMed ID: 9515802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
